Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

February 2013 - FRMC

Pertussis Vaccination and Increase in Cases
02/14/2013

Tori Socha

Tori Socha
Despite an extensive and widely available childhood vaccination program, pertussis remains a poorly controlled vaccine-preventable disease in the United States. Infants have higher rates of pertussis compared with children in other age...
Despite an extensive and widely available childhood vaccination program, pertussis remains a poorly controlled vaccine-preventable disease in the United States. Infants have higher rates of pertussis compared with children in other age...
Despite an extensive and widely...
02/14/2013
First Report Managed Care
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
02/14/2013

Kevin L. Carter

Kevin L. Carter
The treatment of metastatic melanoma has been greatly enhanced by pharmacologic inhibition of the mitogen-activated protein kinase (MAPK) pathway. Trametinib mediates blockade of MAPK kinase (MEK), which is downstream of BRAF in the MAPK...
The treatment of metastatic melanoma has been greatly enhanced by pharmacologic inhibition of the mitogen-activated protein kinase (MAPK) pathway. Trametinib mediates blockade of MAPK kinase (MEK), which is downstream of BRAF in the MAPK...
The treatment of metastatic...
02/14/2013
First Report Managed Care
Rasagiline and Dopamine to Treat Parkinson’s Disease
02/14/2013

Tim Casey

Tim Casey
Berlin, Germany—After controlling for several variables, patients with Parkinson’s disease who began therapy with rasagiline had a significantly lower probability of being hospitalized, significantly fewer hospitalizations, and shorter length...
Berlin, Germany—After controlling for several variables, patients with Parkinson’s disease who began therapy with rasagiline had a significantly lower probability of being hospitalized, significantly fewer hospitalizations, and shorter length...
Berlin, Germany—After...
02/14/2013
First Report Managed Care
Comparison of Oral Contraceptive Therapies
02/14/2013

Tim Casey

Tim Casey
Berlin, Germany—A database analysis of insured women found that those who took 84 days of levonorgestrel/ethinyl estradiol plus ethinyl estradiol 0.01 mg for 7 days were significantly less likely to become pregnant compared with those who...
Berlin, Germany—A database analysis of insured women found that those who took 84 days of levonorgestrel/ethinyl estradiol plus ethinyl estradiol 0.01 mg for 7 days were significantly less likely to become pregnant compared with those who...
Berlin, Germany—A database...
02/14/2013
First Report Managed Care
Costs and Healthcare Utilization with Myeloproliferative Neoplasms
02/14/2013

Tim Casey

Tim Casey
Atlanta—A retrospective cohort analysis found that total healthcare costs for Medicare patients with myeloproliferative neoplasms (MPNs) were 1.5 to 3 times higher and hospitalizations were significantly higher compared with a matched control...
Atlanta—A retrospective cohort analysis found that total healthcare costs for Medicare patients with myeloproliferative neoplasms (MPNs) were 1.5 to 3 times higher and hospitalizations were significantly higher compared with a matched control...
Atlanta—A retrospective cohort...
02/14/2013
First Report Managed Care
Phase 2 Trial of Quizartinib in AML Patients
02/14/2013

Tim Casey

Tim Casey
Atlanta—A phase 2, open-label trial found that a subset of patients with double refractory, treatment-resistant acute myeloid leukemia (AML) achieved a clinically meaningful high response rate when taking quizartinib, an oral investigational...
Atlanta—A phase 2, open-label trial found that a subset of patients with double refractory, treatment-resistant acute myeloid leukemia (AML) achieved a clinically meaningful high response rate when taking quizartinib, an oral investigational...
Atlanta—A phase 2, open-label...
02/14/2013
First Report Managed Care
Apixaban to Treat Venous Thromboembolism
02/14/2013

Tim Casey

Tim Casey
Atlanta—Patients who took 2.5 mg or 5 mg of apixaban twice daily for 1 year had an 80% risk reduction in recurrent nonfatal or fatal venous thromboembolism (VTE) compared with those who received placebo, according to a randomized,...
Atlanta—Patients who took 2.5 mg or 5 mg of apixaban twice daily for 1 year had an 80% risk reduction in recurrent nonfatal or fatal venous thromboembolism (VTE) compared with those who received placebo, according to a randomized,...
Atlanta—Patients who took 2.5 mg...
02/14/2013
First Report Managed Care
Phase 1/2 Trial of MLN9708 for Multiple Myeloma
02/14/2013

Tim Casey

Tim Casey
Atlanta—Patients with previously untreated multiple myeloma, who took the investigational agent MLN9708 in combination with lenalidomide and dexamethasone, responded well to the drug regimen and tolerated the treatment, according to a phase...
Atlanta—Patients with previously untreated multiple myeloma, who took the investigational agent MLN9708 in combination with lenalidomide and dexamethasone, responded well to the drug regimen and tolerated the treatment, according to a phase...
Atlanta—Patients with previously...
02/14/2013
First Report Managed Care
Ponatinib for Patients with Rare Types of Leukemia
02/14/2013

Tim Casey

Tim Casey
Atlanta—After a median >12 months of treatment, patients with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who took ponatinib responded well to the drug, according to a phase 2,...
Atlanta—After a median >12 months of treatment, patients with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who took ponatinib responded well to the drug, according to a phase 2,...
Atlanta—After a median >12...
02/14/2013
First Report Managed Care

Department

Conference Insider
Dabigatran Etexilate for Total Hip and Knee Replacement
02/14/2013

Tim Casey

Tim Casey
Atlanta—Patients undergoing total hip or knee replacement who took 220 mg of dabigatran etexilate daily had few major bleeding events regardless of their body mass index (BMI), renal function, or age, according to an international,...
Atlanta—Patients undergoing total hip or knee replacement who took 220 mg of dabigatran etexilate daily had few major bleeding events regardless of their body mass index (BMI), renal function, or age, according to an international,...
Atlanta—Patients undergoing...
02/14/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Drug Makers to Justify Costs, Disclose Price Hikes under Proposed California Law
06/28/2016
A recently proposed California law that would require drug makers to justify the costs of their treatments and disclose any major price hikes has invoked strong opposition from the pharmaceutical industry. 
A recently proposed California law that would require drug makers to justify the costs of their treatments and disclose any major price hikes has invoked strong opposition from the pharmaceutical industry. 
A recently proposed California...
06/28/2016
First Report Managed Care
News
Audits Reveal Millions in Medicare Advantage Overcharges
11/21/2022

Fred Schulte and Holly Hacker

Fred Schulte and Holly Hacker, Kaiser...
Newly released federal audits showed Medicare Advantage plans overbilled the government by approximately $12 million.
Newly released federal audits showed Medicare Advantage plans overbilled the government by approximately $12 million.
Newly released federal audits...
11/21/2022
First Report Managed Care
Prostate Cancer Treatments Pose Challenges for Managed Care
11/29/2011

Tim Casey

Tim Casey
Atlanta—With the introduction of several new therapies, the treatment for castration-resistant prostate cancer (CRPC) has gone through a dramatic shift in recent years. By the end of the decade, the market for prostate cancer is expected to...
Atlanta—With the introduction of several new therapies, the treatment for castration-resistant prostate cancer (CRPC) has gone through a dramatic shift in recent years. By the end of the decade, the market for prostate cancer is expected to...
Atlanta—With the introduction of...
11/29/2011
First Report Managed Care
News
As Medicaid Budgets Squeezed, States Consider Eccentric Ideas On Cutting Costs
03/30/2011
03/30/2011
First Report Managed Care
News
Progress Made on How Medicare Pays Doctors
05/10/2012
05/10/2012
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

February 2013 Volume 10 Issue 2

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement